Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 5.05 Billion DKK | 5.62% |
| 2023 | 4.78 Billion DKK | 1.64% |
| 2022 | 4.7 Billion DKK | -2.47% |
| 2021 | 4.82 Billion DKK | 14.96% |
| 2020 | 4.19 Billion DKK | 8.37% |
| 2019 | 3.87 Billion DKK | 0.73% |
| 2018 | 3.84 Billion DKK | 1.26% |
| 2017 | 3.79 Billion DKK | 20.81% |
| 2016 | 3.14 Billion DKK | 249.61% |
| 2015 | 899 Million DKK | -62.38% |
| 2014 | 2.39 Billion DKK | -11.84% |
| 2013 | 2.71 Billion DKK | 23.56% |
| 2012 | 2.19 Billion DKK | 20.62% |
| 2011 | 1.81 Billion DKK | 46.34% |
| 2010 | 1.24 Billion DKK | 40.77% |
| 2009 | 883 Million DKK | 23.5% |
| 2008 | 715 Million DKK | -14.58% |
| 2007 | 837 Million DKK | 36.32% |
| 2006 | 614 Million DKK | 11.03% |
| 2005 | 553 Million DKK | -5.93% |
| 2004 | 587.88 Million DKK | 4.79% |
| 2003 | 561 Million DKK | -26.95% |
| 2002 | 768 Million DKK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.21 Billion DKK | -1.38% |
| 2024 Q3 | 1.27 Billion DKK | 1.76% |
| 2024 Q2 | 1.25 Billion DKK | 3.3% |
| 2023 FY | 4.78 Billion DKK | 1.64% |
| 2023 Q2 | 1.15 Billion DKK | 2.48% |
| 2023 Q1 | 1.12 Billion DKK | -8.37% |
| 2023 Q4 | 1.22 Billion DKK | -3.38% |
| 2023 Q3 | 1.27 Billion DKK | 10.13% |
| 2022 Q1 | 1.2 Billion DKK | -7.51% |
| 2022 FY | 4.7 Billion DKK | -2.47% |
| 2022 Q4 | 1.23 Billion DKK | -4.58% |
| 2022 Q3 | 1.28 Billion DKK | 31.53% |
| 2022 Q2 | 980 Million DKK | -18.81% |
| 2021 FY | 4.82 Billion DKK | 14.96% |
| 2021 Q1 | 1.13 Billion DKK | 9.13% |
| 2021 Q2 | 1.13 Billion DKK | -0.53% |
| 2021 Q3 | 1.25 Billion DKK | 10.97% |
| 2021 Q4 | 1.3 Billion DKK | 4.07% |
| 2020 Q4 | 1.04 Billion DKK | 4.41% |
| 2020 Q3 | 997 Million DKK | -6.56% |
| 2020 Q1 | 1.09 Billion DKK | 37.7% |
| 2020 FY | 4.19 Billion DKK | 8.37% |
| 2020 Q2 | 1.06 Billion DKK | -2.29% |
| 2019 Q3 | 1.06 Billion DKK | 4.6% |
| 2019 FY | 3.87 Billion DKK | 0.73% |
| 2019 Q1 | 991 Million DKK | -4.62% |
| 2019 Q2 | 1.02 Billion DKK | 3.03% |
| 2019 Q4 | 793 Million DKK | -25.75% |
| 2018 FY | 3.84 Billion DKK | 1.26% |
| 2018 Q1 | 940 Million DKK | -6.93% |
| 2018 Q4 | 1.03 Billion DKK | 9.6% |
| 2018 Q3 | 948 Million DKK | 3.27% |
| 2018 Q2 | 918 Million DKK | -2.34% |
| 2017 Q4 | 1.01 Billion DKK | 10.99% |
| 2017 Q3 | 910 Million DKK | -2.26% |
| 2017 Q1 | 946 Million DKK | 123.11% |
| 2017 FY | 3.79 Billion DKK | 20.81% |
| 2017 Q2 | 931 Million DKK | -1.59% |
| 2016 FY | 3.14 Billion DKK | 249.61% |
| 2016 Q2 | 916 Million DKK | 11.03% |
| 2016 Q3 | 978 Million DKK | 6.77% |
| 2016 Q1 | 825 Million DKK | 158.02% |
| 2016 Q4 | 424 Million DKK | -56.65% |
| 2015 Q3 | 709 Million DKK | -13.01% |
| 2015 FY | 899 Million DKK | -62.38% |
| 2015 Q1 | 797 Million DKK | -5.23% |
| 2015 Q2 | 815 Million DKK | 2.26% |
| 2015 Q4 | -1.42 Billion DKK | -300.56% |
| 2014 Q1 | 780 Million DKK | 4.14% |
| 2014 Q3 | 788 Million DKK | 4247.37% |
| 2014 FY | 2.39 Billion DKK | -11.84% |
| 2014 Q4 | 841 Million DKK | 6.73% |
| 2014 Q2 | -19 Million DKK | -102.44% |
| 2013 Q1 | 617 Million DKK | 1.48% |
| 2013 FY | 2.71 Billion DKK | 23.56% |
| 2013 Q4 | 749 Million DKK | 5.49% |
| 2013 Q3 | 710 Million DKK | 11.81% |
| 2013 Q2 | 635 Million DKK | 2.92% |
| 2012 Q3 | 588 Million DKK | 14.4% |
| 2012 Q4 | 608 Million DKK | 3.4% |
| 2012 Q2 | 514 Million DKK | 6.2% |
| 2012 FY | 2.19 Billion DKK | 20.62% |
| 2012 Q1 | 484 Million DKK | -8.85% |
| 2011 Q2 | 396 Million DKK | -2.7% |
| 2011 Q1 | 407 Million DKK | 10.6% |
| 2011 FY | 1.81 Billion DKK | 46.34% |
| 2011 Q3 | 485 Million DKK | 22.47% |
| 2011 Q4 | 531 Million DKK | 9.48% |
| 2010 Q1 | 276 Million DKK | 1.47% |
| 2010 FY | 1.24 Billion DKK | 40.77% |
| 2010 Q4 | 368 Million DKK | 9.2% |
| 2010 Q3 | 337 Million DKK | 28.63% |
| 2010 Q2 | 262 Million DKK | -5.07% |
| 2009 Q2 | 188 Million DKK | -6.93% |
| 2009 Q1 | 202 Million DKK | 0.0% |
| 2009 FY | 883 Million DKK | 23.5% |
| 2009 Q4 | 272 Million DKK | 23.08% |
| 2009 Q3 | 221 Million DKK | 17.55% |
| 2008 FY | 715 Million DKK | -14.58% |
| 2007 FY | 837 Million DKK | 36.32% |
| 2006 FY | 614 Million DKK | 11.03% |
| 2005 FY | 553 Million DKK | -5.93% |
| 2004 FY | 587.88 Million DKK | 4.79% |
| 2003 FY | 561 Million DKK | -26.95% |
| 2002 FY | 768 Million DKK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 545146.731% |
| Ansell Limited | 76.5 Million USD | -6503.922% |
| Ansell Limited | 76.5 Million USD | -6503.922% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -20707.077% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 309992.452% |
| Psykey, Inc. | -1.32 Million USD | 381685.119% |
| ConvaTec Group Plc | 130.3 Million USD | -3777.206% |
| ConvaTec Group Plc | 130.3 Million USD | -3777.206% |
| Encision Inc. | -691.78 Thousand USD | 730386.81% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 3562588.1% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 2155702.775% |
| Innovative MedTech Inc. | -7.93 Million USD | 63736.044% |
| LifePoint, Inc. | -15.23 Million USD | 33267.894% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 74274.13% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 1065922.785% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 1840899.283% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 1100686.457% |
| SmileDirectClub, Inc. | -86.4 Million USD | 5946.952% |
| Sector 10, Inc. | 7036.00 USD | -71802060.318% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -152.36% |
| SheerVision, Inc. | -71.37 Thousand USD | 7078109.415% |
| United Health Products, Inc. | -2.62 Million USD | 192684.285% |
| Vasamed, Inc. | -4.88 Million USD | 103451.92% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 211616.425% |
| Yubo International Biotech Limited | -1.2 Million USD | 419434.891% |